This year's sessions comprise:
- Societal and medical need: new gene- and cell-based therapies
- Cooperation of academia and industry
- Compliance: no conflict – no interest
- Building startups
- Venture creation and commercialisation of discoveries: best practice models
- National strategy for cell and gene therapy